{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"mixed-fibrolamellar-hepatocellular-carcinoma","columns":[{"gene":"","key":"population-d52b47a86164370eb603","label":"mixed fibrolamellar hepatocellular carcinoma","mondoId":"MONDO:0000891","onsetQualifier":null,"originColumnKey":"MONDO:0000891/no-native-evidence","originalViews":[{"key":"MONDO:0000891/no-native-evidence","label":"mixed fibrolamellar hepatocellular carcinoma","scopeLabel":"No safely mapped HPO entry","sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"recordKeys":[],"recordQualifiers":{},"scopeLabel":"No safely mapped HPO entry","sourceIds":[],"sourceScope":"MONDO establishes family membership. No separately scoped phenotype population is safely linked here; parent and sibling values are not copied."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-d52b47a86164370eb603"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":["population-d52b47a86164370eb603"],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A fibrolamellar carcinoma that is characterized by the presence of both pure fibrolamellar hepatocellular carcinoma and and conventional hepatocellular carcinoma components.","mondoId":"MONDO:0000891","node":{"canonicalSlug":"mixed-fibrolamellar-hepatocellular-carcinoma","comparisons":[{"documentSha256":"7c4f23f29b9b7fc1ab8826add26305486810e7e09eb86cee00d12aa79cd69e6d","key":"expanded-carcinoma-of-liver-and-intrahepatic-biliary-tract","kind":"expanded","label":"carcinoma of liver and intrahepatic biliary tract","memberIds":["MONDO:0000891","MONDO:0003210","MONDO:0003243","MONDO:0003245","MONDO:0003246","MONDO:0003650","MONDO:0003651","MONDO:0004078","MONDO:0004315","MONDO:0004346","MONDO:0004451","MONDO:0004715","MONDO:0006210","MONDO:0006268","MONDO:0007256","MONDO:0015072","MONDO:0016216","MONDO:0018055","MONDO:0018531","MONDO:0018533","MONDO:0018534","MONDO:0018535","MONDO:0018666","MONDO:0044788","MONDO:0044791","MONDO:0056815","MONDO:0100132"],"mondoId":"MONDO:0018531","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-7c4f23f29b9b7fc1ab88.7c4f23f29b9b7fc1ab8826add26305486810e7e09eb86cee00d12aa79cd69e6d.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"mixed fibrolamellar hepatocellular carcinoma","paragraphs":["A fibrolamellar carcinoma that is characterized by the presence of both pure fibrolamellar hepatocellular carcinoma and and conventional hepatocellular carcinoma components."],"scope":"exact","source":"MONDO","upstream":"DOID:0080182, https://wjso.biomedcentral.com/articles/10.1186/s12957-016-0903-8, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880064/","url":"https://monarchinitiative.org/MONDO:0000891"},"ownColumnKeys":["population-d52b47a86164370eb603"],"publication":"published","relationships":[{"kind":"parent","label":"fibrolamellar hepatocellular carcinoma","mondoId":"MONDO:0006210","slug":"fibrolamellar-hepatocellular-carcinoma"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/22839"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0000891\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>DOID:0080182, https://wjso.biomedcentral.com/articles/10.1186/s12957-016-0903-8, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880064/</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A fibrolamellar carcinoma that is characterized by the presence of both pure fibrolamellar hepatocellular carcinoma and and conventional hepatocellular carcinoma components.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0000891\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"mixed-fibrolamellar-hepatocellular-carcinoma","sourceDocuments":[{"name":"MONDO: mixed fibrolamellar hepatocellular carcinoma","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0000891"}],"sourceNote":"","synonyms":[],"takeawayHtml":"","title":"mixed fibrolamellar hepatocellular carcinoma"},"schemaVersion":1}
